2023 ISPE Biotechnology Conference
The 2023 ISPE Biotechnology Conference in Dublin from 26-27 June 2023, will give an overall view of the development and manufacturing of biotechnology products.
For the current originator pharmaceuticals, like mABs or vaccines, the challenges to increase productivity, process intensification, flexibility, and agility are distinctive when it comes to mass production. The conference will present and discuss modular facility design and collaborative project delivery.
The focus is on different challenges for innovative, biosimilar, and follow-up biotechnology products, like cell and gene therapy, Advanced Therapeutic Medicinal Products (ATMPs), and mRNA-based products – such as vaccines. The conference will feature presentations with a focus on time to market, shortened submission approval times, product transfer, new concepts for control strategy, quality oversight, manufacturing, and logistics.
The 2023 ISPE Biotechnology Conference will focus on the overarching themes that represent learnings from the originator pharmaceutical products that can be applied and transferred to the (new) biosimilar and follow-up biotechnology products. Methodological enablers for process development, supply chain resiliency, and more critically, driven by the energy crisis, sustainability will be the primary focus of our event. Discussions will be presented and considered within the current regulatory framework.
Arcadis DPS Group will be exhibiting at this conference and will also be speaking on Tuesday 27th June at 11:15am in the ATMPs/C>s: From Concept to Commercialisation track:
Topic: Flexible and Multi-Modal ATMP Facilities
Speakers: Stephen Judd, Process SME – Biologics / Cell & Gene Therapy and William Whitford, Global Solutions Leader